Experiment 644657

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationIVANIV,OP:. (1998). THE RESULTS OF USING DIFFERENT FORMS OF GINKGO BILOBA EXTRACT (GBE 761) IN A MULTIPLE-MODALITY TREATMENT OF PATIENTS WITH DISCIRCULATORY ENCEPHALOPATHY.. 1998(8)
Amount utilized
Compound isolated
DiseaseSTUDIES MADE IN 208 PATIENTS WITH DISCIRCULATORY ENCEPHALOPATHY USING CLINICAL AND NEUROPSYCHOLOGICAL TESTS. APPARATUS (REG. ECG. EEG. DOPPLERSONOGRAPHY) AND LABORATORY (COAGULOGRAMME) METHODS SHOWED THE PRESCRIPTION OF DRUG PREPARATIONS FROM GINKGO EXTRACT TO BE A WORTH-WHILE EXERCISE LIKELY TO BENEFIT THE PATIENT DURING DIFFERENT STAGES OF HIS/HER AFFECTION. POSITIVE TIME-RELATED COURSE WAS RECORDABLE OF CHANGE IN ELASTIC-AND-TONIC CHARACTERISTICS OF VESSELS, OF BIOELECTRIC BRAIN ACTIVITY, EMOTIONAL-AND-BEHAVIORAL, COGNITIVE AND MNESTIC FEATURES. THE ABOVE-MENTIONED DRUGS WILL, WE BELIEVE, HELP IN DEVELOPING NEW OPTIONS FOR THE OUTPATIENT. HOSPITAL, AND REHABILITATIVE STAGE OF MANAGING A PATIENT. POTENTIATION OF THE POSITIVE ACTION OF GINKGO PREPARATIONS SHOWED UP WHEN BEING COMBINED WITH A COMPLEX OF COMPONENTS OF THE TRICARBOXYLIC ACID CYCLE. A COMMERCIAL PRODUCT, EGB-761, WAS USED.
Dose amountVAR
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractACETONE EXT